Clinical Failure Rates Stuck at 90%: No Productivity Gains Since 1970s
A new review of clinical trial data shows the failure rate has hovered around 90% for the past three decades, barely better than the 80% seen in the 1970s‑80s. For biotech founders and investors, this steady high attrition underscores the persistent risk in drug development and the need for smarter target selection.